CEBPB and coronary artery disorder: Either preserving MAPK7-CEBPβ or directly impinging mir128-3p appears to be a potential approach to mitigate cardiac injury and could be an adjunctive treatment option in combination with surgical interventions for patients with ischemic heart disease.